================================================================================

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
     EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2007

                                       OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from ________________ to ___________________

Commission file number: 000-50292

                                 MM2 GROUP, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          NEW JERSEY                                             20-2554835
--------------------------------------------------------------------------------
(State or other jurisdiction of                               (I.R.S. Employer
 incorporation or organization)                              Identification No.)


     5 REGENT STREET, SUITE 520
           LIVINGSTON, NJ                                          07039
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                        (Zip Code)

Registrant's Telephone Number, Including Area Code: (732) 290-0019

The former name of the registrant was Wien Group, Inc. The former address of the
registrant was 525 Washington Blvd., Jersey City, New Jersey, 07310

Securities registered under Section 12(b) of the Exchange Act: NONE.

Securities registered under Section 12(g) of the Exchange Act: CLASS A COMMON,
NO PAR VALUE

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. YES __X__ NO ____ ---

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). YES [ ] NO [X]


Number of shares of Class A, common stock,
            No par value, outstanding as of May 15, 2007: 145,727,523

Transitional Small Business Disclosure Format (check one).  YES [ ] NO [X]
================================================================================
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
                   CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                 MARCH 31, 2007


                                TABLE OF CONTENTS


                                                                        Page No.

PART I.                      FINANCIAL INFORMATION

Item 1.  Condensed Consolidated Financial Statements (Unaudited)

         Balance Sheet - March 31, 2007                                   2 - 3

         Statements of Operations - For the nine months and
           three months ended March 31, 2007 and 2006                       4

         Accumulated Other Comprehensive Loss - For the nine
           months ended March 31, 2007                                      5

         Statements of Cash Flows - For the nine months ended
                  March 31, 2007 and 2006                                 6 - 8

         Notes to Condensed Consolidated Financial Statements             9 - 27

Item 2.  Management's Discussion and Analysis or Plan of Operations      28 - 32

Item 3.  Controls and Procedures                                         33 - 34

PART II. OTHER INFORMATION

Item 6.  Exhibits                                                          35

                                        1
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
                CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED)
                                 MARCH 31, 2007

ASSETS
------

CURRENT ASSETS
Cash and cash equivalents                                          $    727,879
Securities available for sale                                           280,000
Accounts receivable, net of allowance for doubtful
  accounts of $0                                                        290,029
Inventory                                                               243,106
Prepaid expenses                                                        103,380
                                                                   ------------
    Total current assets                                              1,644,394
                                                                   ------------

PROPERTY AND EQUIPMENT, net of accumulated
  depreciation of $2,009                                                  4,618
                                                                   ------------

OTHER ASSETS
Goodwill                                                                250,729
Deferred financing costs, net of accumulated
  amortization of $7,812                                                 23,438
Deposits and other assets                                                 3,183
                                                                   ------------
    Total other assets                                                  277,350
                                                                   ------------

TOTAL ASSETS                                                       $  1,926,362
                                                                   ============

LIABILITIES AND STOCKHOLDERS' DEFICIT
-------------------------------------

CURRENT LIABILITIES
Accounts payable and accrued expenses                              $    761,171
Due to related parties                                                  684,445
Deferred income                                                         840,000
Convertible debentures payable, net of discount of
  $1,272,972                                                            632,336
Derivative liability                                                  1,769,516
Warrant liability                                                     1,009,437
                                                                   ------------
    Total current liabilities                                         5,696,905
                                                                   ------------

TOTAL LIABILITIES                                                     5,696,905
                                                                   ============

COMMITMENTS AND CONTINGENCIES

         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        2
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
          CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED) (CONTINUED)
                                 MARCH 31, 2007


TEMPORARY EQUITY
Common stock: Class B - no par value, authorized
  50,000,000 shares; 10,000,000 shares issued and
  outstanding                                                               882
                                                                   ------------

STOCKHOLDERS' DEFICIT
Preferred stock, $1.00 par value; authorized 1,000,000 shares;
    no shares issued and outstanding                                         --
Common stock:
   Class A - no par value; authorized 450,000,000 shares;
       145,727,523 shares issued and outstanding                        902,546
   Class B - no par value; authorized 50,000,000 shares;
       10,000,000 shares issued and outstanding                             118
Additional paid-in capital                                              824,621
Accumulated other comprehensive loss                                   (840,000)
Accumulated deficit                                                  (4,658,710
                                                                   ------------
   Total stockholders' deficit                                       (3,771,425)
                                                                   -------------

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                        $  1,926,362
                                                                   ============


         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        3
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
       FOR THE NINE MONTHS AND THREE MONTHS ENDED MARCH 31, 2007 AND 2006
<TABLE><CAPTION>
                                                    For the Nine Months ended    For the three months ended
                                                            March 31,                     March 31,
                                                       2007            2006          2007            2006
                                                   ------------   ------------   ------------   ------------
                                                                   (restated)                    (restated)

<S>                                                <C>            <C>            <C>            <C>
SALES, net                                         $    674,230   $       --     $    247,954   $       --

COST OF SALES                                           250,864           --           96,610           --
                                                   ------------   ------------   ------------   ------------

GROSS PROFIT                                            423,366           --          151,344           --
                                                   ------------   ------------   ------------   ------------

GENERAL AND ADMINISTRATION
  EXPENSES
  Selling and marketing expenses                         27,960           --           20,460           --
  General and administrative expenses                 1,197,307        556,971        615,118        185,422
  Depreciation expenses                                     994            665            551            222
  Amortization of financing costs                         7,812           --            7,812           --
                                                   ------------   ------------   ------------   ------------

  Total general and administration expenses           1,234,073        557,636        643,941        185,644
                                                   ------------   ------------   ------------   ------------

(LOSS) FROM OPERATIONS                                 (810,707)      (557,636)      (492,597)      (185,644)
                                                   ------------   ------------   ------------   ------------

OTHER (INCOME) EXPENSES
  Other (income)                                       (337,816)       (21,248)      (288,496)        (6,533)
  Interest expense                                      108,589        130,902         46,460         15,624
  Liquidated damages                                    119,531           --           38,107       (150,000)
  (Gain) Loss on revaluation of derivatives              57,382           --         (766,235)          --
  Amortization of discount on debt conversion           513,783        500,000        223,344           --
  Write-off of financing costs                          369,625      1,005,004           --          964,812
                                                   ------------   ------------   ------------   ------------

  Total other (income) expenses                         831,094      1,614,658       (746,820)       823,903
                                                   ------------   ------------   ------------   ------------

INCOME (LOSS) BEFORE PROVISION FOR
  INCOME TAXES                                       (1,641,801)    (2,172,294)       254,223     (1,009,547)

PROVISION FOR INCOME TAXES                                 --             --             --             --
                                                   ------------   ------------   ------------   ------------

NET INCOME (LOSS) APPLICABLE TO
    COMMON SHARES                                  $ (1,641,801)  $ (2,172,294)  $    254,223   $ (1,009,547)
                                                   ============   ============   ============   ============

NET INCOME (LOSS) PER COMMON SHARE
  Basic and diluted                                $      (0.01)  $      (0.02)  $       0.00   $      (0.01)
                                                   ============   ============   ============   ============

WEIGHTED AVERAGE SHARES OUTSTANDING
  Basic and diluted                                 138,179,546    123,315,251    144,349,948    123,315,251
                                                   ============   ============   ============   ============
</TABLE>

         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        4
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
    CONDENSED CONSOLIDATED STATEMENT OF ACCUMULATED OTHER COMPREHENSIVE LOSS
                                   (UNAUDITED)
                    FOR THE NINE MONTHS ENDED MARCH 31, 2007



Balance at July 1, 2006                                            $       --

Unrealized loss on securities available for sale:
 Unrealized losses arising during the period        $   (840,000)
                                                    ------------
 Net change for the period                                             (840,000)
                                                                   ------------
Balance at March 31, 2007                                          $   (840,000)
                                                                   ============






















              The accompanying notes are an integral part of these
                  condensed consolidated financial statements.

                                        5
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
                FOR THE NINE MONTHS ENDED MARCH 31, 2007 AND 2006
<TABLE><CAPTION>

                                                                      2007           2006
                                                                  ------------   ------------
CASH FLOW FROM OPERATING ACTIVITIES                                               (restated)
<S>                                                               <C>            <C>
 Net (loss)                                                       $ (1,641,801)  $ (2,172,294)
 Adjustments to reconcile net (loss) to net cash (used in)
   operating activities
      Depreciation                                                         994            665
      Common stock issued for services                                 226,546           --
      Amortization of discount on debt conversion                      513,783        500,000
      Amortization of prepaid financing costs                            7,812           --
      Loss on revaluation of derivatives                                57,382           --
      Gain on disposition of derivative liability                      (40,192)          --
      Write-off of financing costs                                     369,625      1,005,004
      Securities received for consulting income                       (280,000)          --
      Changes in operating assets and liabilities:
      Accounts receivable                                             (111,027)          --
      Inventory                                                       (208,915)          --
      Prepaid expenses and other assets                                 (1,065)       (66,477)
      Accounts payable and accrued liabilities                         490,945         89,884
      Due to related parties                                           216,390        200,222
                                                                  ------------   ------------
 Total cash (used in) operating activities                            (399,523)      (442,996)
                                                                  ------------   ------------

CASH FLOWS FROM INVESTING ACTIVITIES
 Purchase of property and equipment                                     (2,196)          (556)
                                                                  ------------   ------------
 Total cash (used in) investing activities                              (2,196)          (556)
                                                                  ------------   ------------

CASH FLOWS FROM FINANCING ACTIVITIES
 Proceeds from debt financing                                          625,000           --
                                                                  ------------   ------------
 Total cash provided by financing activities                           625,000           --
                                                                  ------------   ------------

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                   223,281       (443,552)

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD                        504,598      1,034,799
                                                                  ------------   ------------

CASH AND CASH EQUIVALENTS - END OF PERIOD                         $    727,879   $    591,247
                                                                  ============   ============

SUPPLEMENTAL CASH FLOW INFORMATION Cash paid during
 the period for:
 Interest expense                                                 $       --     $       --
                                                                  ============   ============
 Income taxes                                                     $       --     $       --
                                                                  ============   ============
</TABLE>

         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        6
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
     CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED)
                FOR THE NINE MONTHS ENDED MARCH 31, 2007 AND 2006


      SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTING ACTIVITIES

For the nine months ended March 31, 2007, the Company:
------------------------------------------------------

Issued 1,849,689 shares of Class A common stock with a total value of $120,230,
which represents full satisfaction of the Commitment Shares under the Standby
Equity Distribution Agreement, pursuant to the Termination Agreement of July 20,
2006.

Issued 3,150,311 shares of Class A common stock with a total value of $204,770,
for Commitment Shares pursuant to the Amended and Restated Securities Purchase
Agreement of July 20, 2006.

Issued 600,000 shares of its Class A common stock with a total value of $30,000,
as compensation to Stephen Wien for services provided.

Issued 300,000 shares of its Class A common stock with a total value of $10,500,
as compensation for the consulting services with Allison Investment Corp. on
matters related to mergers and acquisitions.

Issued 825,852 shares of its Class A common stock with a total value of $45,046,
as compensation for the strategic alliance with UTEK Corporation to identify
synergistic technology acquisition opportunities.

On September 21, 2006, the Company concluded the acquisition of Genotec
Nutritionals, Inc. Pursuant to the Asset Purchase Agreement, the Company issued
10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato. The net effect
on cash flows is as follows:

         Accounts receivable                       $    179,002
         Inventory                                       34,191
         Prepaid expenses                                 2,149
         Security deposit                                 3,183
         Goodwill                                       250,729
         Accounts payable and accrued expense          (169,254)
         Common stock                                  (300,000)
                                                   ------------
         Total                                     $       --
                                                   ============

Issued 100,000 restricted shares of its Class A common stock with a total value
of $4,000, to Dr. Yevsey Belinky for the continuing development of a new cardiac
supplement product line.

Issued 500,000 restricted shares of its Class A common stock with a total value
of $25,000, to William Maier pursuant to his consulting agreement for product
marketing services.

         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        7
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
     CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED)
                FOR THE NINE MONTHS ENDED MARCH 31, 2007 AND 2006


      SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTING ACTIVITIES

For the nine months ended March 31, 2007, the Company (Continued):

Issued 3,086,420 shares of Class A common stock to Cornell Capital Partners as
repayment of principal on outstanding convertible debentures, valued at $50,000.

The Company received 4,000,000 shares of Class A common stock of Deep Field
Technologies as compensation for consulting services to be provided pursuant to
the terms of the Consulting Agreement entered into on February 13, 2007. The
value of the agreement was determined to be $1,120,000 and is being amortized
over six months ending August 13, 2007.

Issued 2,000,000 restricted shares of its' Class A Common Stock with a total
value of $112,000, to Dr. Jeffrey Shapiro, and his assignees, as a partial fee
for joining the Company's Board of Scientific Advisors and for providing the
Company consulting services relating to the development of a new cardiac
supplement product line.

For the nine months ended March 31, 2006:

On June 24, 2005, the Company's Board of Directors declared a one-for-one stock
dividend of the common stock payable on July 29, 2005 to shareholders of record
as of July 11, 2005. The Company issued 3,689,636 shares.

On October 19, 2005, the Company issued a total of 115,933,332 shares of Class A
Common Stock and 10,000,000 shares of Class B Common Stock to Mr. Mahoney and
Mr. Meller pursuant to the terms of the Acquisition Agreement in exchange for
the outstanding shares of Old MM2's Class A Common Stock and Class B Common
Stock.



         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        8
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Description of business
MM2 Group, Inc. ("MM2", or the "Company"), was incorporated in New York on March
18, 1968 under the name John DeNegris Associates, Inc. In 1974, John DeNegris
Associates, Inc. changed its name to Wien Group, Inc. ("Wien (NY)"). Wien (NY)
conducted a public relations business and traded in the public market until
December 1991 when the corporation ceased operations. Wien (NY) remained
inactive until September 1998 when it reacquired its good standing status with
the State of New York. Wien (NY) did not conduct any business prior to July
2001, at which time it initiated its business of providing corporate financial
advisory services to small and emerging companies that require advisory services
to continue their growth within their respective industries. Wien (NY) primarily
focused on the manufacturing, retail, music & entertainment, and health care
industries. These services include: general corporate finance, merger and
acquisition advisory services, consulting on overall corporate strategy,
facilitating asset-based lending, and arranging equipment leasing contracts.

On September 23, 2005, Wien (NY) reincorporated in the state of New Jersey
pursuant to a Plan and Agreement of Merger. Pursuant to such Plan and Agreement
of Merger, Wien (NY) merged with and into its wholly owned subsidiary ("Wien
(NJ)") with Wien (NJ) being the surviving entity. Wien (NJ)'s charter provided
for the authorization of Class A Common Stock (the "Wien (NJ) Class A Common"),
Class B Common Stock ("Wien (NJ) Class B Common"), and Preferred Stock ("Wien
(NJ) Preferred"). Pursuant to the Plan and Agreement of Merger, each holder of
Wien (NY)'s Common Stock received one share of Wien (NJ) Class A Common in
exchange for each share of such holder's Common Stock.

On October 12, 2005, Wien (NJ)'s name was changed to MM2 Group, Inc.

On October 19, 2005, Wien (NJ) completed its previously disclosed acquisition
(the "Acquisition") of all of the outstanding shares of MM2 Group, Inc., a New
Jersey corporation ("OldMM2"). The Acquisition was effected pursuant to the
terms of the Acquisition Agreement dated July 8, 2005 (the "Acquisition
Agreement") between Wien (NY), Wien (NJ), Stephen Wien, OldMM2 and the
stockholders of OldMM2 as of the date of the Acquisition Agreement. Prior to the
closing of the Acquisition, certain terms and conditions of the Acquisition
Agreement were amended by the parties thereto. The primary changes were to (i)
allow fractional shares of Wien (NJ) to be issued in connection with the
Acquisition (ii) correctly state the authorized capital stock of Wien (NJ) and
Wien (NY) and (iii) specify the authorized stock of Wien (NJ) following the
reincorporation.

The Company had nominal operations immediately before and after the Acquisition.
OldMM2 was a corporation formed on December 8, 2004. Other than the Acquisition,
no significant business activity has been conducted by OldMM2 from the date of
its creation to the date of the consummation of the Acquisition. The primary
activity of OldMM2 involved seeking merger or acquisition candidates with whom
it could either merge or acquire.

The Company is publicly traded and is currently traded on the NASD Over The
Counter Bulletin Board ("OTCBB") under the symbol "MMGP".

                                        9
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (CONTINUED)

Basis of presentation
---------------------
The acquisition was accounted for as a reverse merger under the purchase method
of accounting. Accordingly, MM2 Group, Inc. will be treated as the continuing
entity for accounting purposes. The accompanying financial statements include
the accounts of Old MM2, Wien (NY) and its wholly owned subsidiary Wien (NJ).
These condensed consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States
for financial information and with the instructions to Form 10-QSB and
Regulation S-B. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments (consisting
only of normal recurring adjustments) considered necessary for a fair
presentation have been included. It is suggested that these condensed
consolidated financial statements be read in conjunction with the June 30, 2006
audited financial statements and the accompanying notes thereto filed with the
Securities and Exchange Commission on Form 10-KSB.

On September 21, 2006, the Company completed the acquisition of Genotec
Nutritionals, Inc, a New York based manufacturer and distributor of nutritional
supplements and vitamins. Pursuant to the Asset Purchase Agreement, the Company
issued 10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato. In addition, the
Company executed three-year employment agreements with Mr. Kontonotas, Mr.
Freedman and Ms Blancato and purchased $75,000 of Genotec's Series A Convertible
Preferred Stock which was used to fund the working capital.

The result of operations for the nine months ending March 31, 2007 and 2006, are
not necessarily indicative of the results to be expected for the full year. For
further information, refer to the financial statements and footnotes included in
Form 10-KSB for the year ended June 30, 2006. References to the "Company," "we,"
"us" and "our" refer to MM2 Group Inc.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation
---------------------------
The accompanying condensed consolidated financial statements include the
accounts of the Company and its wholly owned subsidiaries. All significant
inter-company transactions and accounts have been eliminated in consolidation.

Use of Estimates
----------------
The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenue and expenses during
the reporting period. Actual results could differ from those estimates.

                                       10
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Cash and Cash Equivalents
-------------------------
The Company considers all highly liquid investments purchased with original
maturities of three months or less to be cash equivalents. The Company had cash
equivalents at March 31, 2007 of $656,714. The cash equivalents represent
investments in Triple A credit rated money market funds that have 7-day auction
rates competitive with current market conditions.

Concentration of Credit Risk
The Company places its cash in what it believes to be credit-worthy financial
institutions. However, cash balances may exceed FDIC insured levels at various
times during the year. The cash equivalents are not insured. The Company has
uninsured cash balances at March 31, 2007 of $656,714.

Marketable Securities
---------------------
The Company has evaluated its investment policies consistent with FAS No. 115,
Accounting for Certain Investments in Debt and Equity Securities, and determined
that all of its investment securities are to be classified as
available-for-sale. Available-for-sale securities are carried at fair value,
with the unrealized gains and losses reported in Stockholders' Equity under the
caption Accumulated Other Comprehensive Income (Loss).

Fair Value of Financial Instruments
-----------------------------------
The Company estimates that the fair value of all financial instruments at March
31, 2007, as defined in FAS 107, does not differ materially from the aggregate
carrying values of its financial instruments recorded in the accompanying
condensed consolidated balance sheet. The estimated fair value amounts have been
determined by the Company using available market information and appropriate
valuation methodologies. Considerable judgment is required in interpreting
market data to develop the estimates of fair value, and accordingly, the
estimates are not necessarily indicative of the amounts that the Company could
realize in a current market exchange.

Revenue Recognition
-------------------
The Company recognizes revenues when products are shipped from our warehouse or
when the Company is notified that product has been drop-shipped from the
suppliers or from our outsourced packagers.

Accounts Receivables
--------------------
Accounts receivables consist primarily of uncollected invoices for product
sales. Payment terms vary from customer to customer and range from "payment on
delivery" to "60 days" terms. In addition, collection on credit card sales is
generally settled in 5 days. The Company does not provide for customer returns,
but will accommodate customers in special circumstances.

                                       11
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Inventory
---------
Inventory consists primarily of bulk supplies of capsules that are in transit to
one of our outsourced packagers. Additional supplies of capsules and sealed
powders, bottles, caps and shipping containers are stored in our warehouse.
Product shipments from our warehouse are bottled and packaged immediately before
delivery.

Property and Equipment
----------------------
Property and equipment is stated at cost. Depreciation is computed using the
straight-line method based upon the estimated useful lives of the assets,
generally five to seven years. Maintenance and repairs are charged to expense as
incurred.

Financing Costs
---------------
Financing costs consist primarily of commitment fees and broker fees relating to
the issuance of the Company's convertible debentures. These costs are generally
capitalized and amortized over the term of the debenture. In some cases, these
fees are expensed immediately if they relate to expired or terminated
debentures.

Goodwill and Other Intangible Assets
------------------------------------
In September 2001, the FASB issued Statement No. 142 "Goodwill and Other
Intangible Assets". This statement addresses financial accounting and reporting
for acquired goodwill and other intangible assets and supersedes APB Opinion No.
17, Intangible Assets. It addresses how intangible assets that are acquired
individually or with a group of other assets (but not those acquired in a
business combination) should be accounted for in financial statements upon their
acquisition. This Statement also addresses how goodwill and other intangible
assets should be accounted for after they have been initially recognized in the
financial statements. The Company recorded $250,729 in goodwill in its
acquisition of Genotec Nutritionals, Inc. Goodwill is tested for impairment
annually.

Income Taxes
------------
The Company accounts for income taxes in accordance with Statements of Financial
Accounting Standards No. 109, "Accounting for Income Taxes," which requires an
asset and liability approach to financial accounting and reporting for income
taxes. Deferred income taxes and liabilities are computed annually for
differences between the financial statement and the tax basis of assets and
liabilities that will result in taxable or deductible amounts in the future
based on enacted tax laws and rates applicable to the periods in which the
differences are expected to affect taxable income. Valuation allowances are
established when necessary to reduce deferred tax assets to the amount expected
to be realized.

                                       12
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Share-Based Payment
-------------------
On December 16, 2004, the Financial Accounting Standards Board ("FASB")
published Statement of Financial Accounting Standards No. 123 (Revised 2004),
Share-Based Payment ("SFAS 123R"). SFAS 123R requires that compensation cost
related to share-based payment transactions be recognized in the financial
statements. Share-based payment transactions within the scope of SFAS 123R
include stock options, restricted stock plans, performance-based awards, stock
appreciation rights, and employee share purchase plans. The provisions of SFAS
123R are effective for small business issuers as of the first interim period
that begins after December 15, 2005. Accordingly, the Company has implemented
the revised standard in the quarter ending December 31, 2005. The adoption of
FAS 123R has not had any effect on the financial statements of the Company.

The Company measures compensation expense for its non-employee stock-based
compensation under the Financial Accounting Standards Board (FASB) Emerging
Issues Task Force (EITF) Issue No. 96-18, "ACCOUNTING FOR EQUITY INSTRUMENTS
THAT ARE ISSUED TO OTHER THAN EMPLOYEES FOR ACQUIRING, OR IN CONJUNCTION WITH
SELLING, GOODS OR SERVICES". The fair value of the option issued is used to
measure the transaction, as this is more reliable than the fair value of the
services received. Fair value is measured as the value of the Company's common
stock on the date that the commitment for performance by the counterparty has
been reached or the counterparty's performance is complete. The fair value of
the equity instrument is charged directly to compensation expense and additional
paid-in capital.

Basic and Diluted Earnings Per Common Share
-------------------------------------------
SFAS No. 128, "Earnings Per Share" requires presentation of basic earnings per
share ("basic EPS") and diluted earnings per share ("diluted EPS").

The computation of basic EPS is computed by dividing income (loss) available to
common stockholders by weighted average number of common shares during the
period. Diluted earnings per share gives effect to all dilutive potential common
shares outstanding during the period. The computation of diluted EPS does not
assume conversion, exercise, or contingent exercise of securities that would
have an anti-dilutive effect on earnings resulting from the Company's net loss
position.

On June 24, 2005, the Company's Board of Directors declared a 1 for 1 stock
dividend whereby, on July 29, 2005, each holder of record of common stock as of
July 11, 2005, would receive one additional share of common stock for each share
then held. For purposes of calculating the weighted average shares outstanding
used in the earnings per share calculation, the stock dividend has been
retroactively applied for the nine months ended March 31, 2006.

                                       13
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

On October 19, 2005, the Company issued 115,933,332 shares of Class A Common
stock to shareholders of Old MM2 pursuant to the terms of the Acquisition
Agreement. For purposes of calculating the weighted average shares outstanding
used in the earnings per share calculation, these shares have been retroactively
applied for the nine months ended March 31, 2006.

The shares used in the computations are as follows:
<TABLE><CAPTION>
                                           For the nine months         For the three months
                                              Ended March 31,             Ended March 31,
                                            2007          2006          2007          2006
                                        -----------   -----------   -----------   -----------
<S>                                    <C>           <C>           <C>           <C>
Average shares outstanding for
Basic and diluted earnings per share    138,179,546   123,315,251   144,349,948   123,315,251
</TABLE>

The Company had common stock equivalents of 20,750,000 and 750,000 at March 31,
2007 and 2006, respectively.

Comprehensive Income (Loss)
---------------------------
FAS No. 130, "Reporting Comprehensive Income", establishes standards for the
reporting and display of comprehensive income and its components in the
financial statements. The items of other comprehensive income that are typically
required to be displayed are foreign currency items, minimum pension liability
adjustments, and unrealized gains and losses on certain investments in debt and
equity securities. As of March 31, 2007, the Company has several items that
represent comprehensive income, and thus, has included a statement of
comprehensive income (loss).

Derivative Liabilities
----------------------
During April 2003, the Financial Accounting Standards Board issued SFAS 149,
"Amendment of Statement 133 on Derivative Instruments and Hedging Activities."
SFAS 149 amends and clarifies accounting for derivative instruments, including
certain derivative instruments embedded in other contracts, and for hedging
activities under SFAS 133, "Accounting for Derivative Instruments and Hedging
Activities." The statement requires that contracts with comparable
characteristics be accounted for similarly and clarifies when a derivative
contains a financing component that warrants special reporting in the statement
of cash flows. SFAS 149 is effective for contracts entered into or modified
after June 30, 2003, except in certain circumstances, and for hedging
relationships designated after June 30, 2003. The financial statements for the
nine months ended March 31, 2007 include the recognition of the derivative
liability on the underlying securities issuable upon conversion of the Cornell
Convertible Debentures.

                                       14
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Recent Accounting Pronouncement
-------------------------------
On December 16, 2004, the Financial Accounting Standards Board ("FASB")
published Statement of Financial Accounting Standards No. 123 (Revised 2004),
Share-Based Payment ("SFAS 123R"). SFAS 123R requires that compensation cost
related to share-based payment transactions be recognized in the financial
statements. Share-based payment transactions within the scope of SFAS 123R
include stock options, restricted stock plans, performance-based awards, stock
appreciation rights, and employee share purchase plans. The provisions of SFAS
123R are effective for small business issuers as of the first interim period
that begins after December 15, 2005. Accordingly, the Company implemented the
revised standard in the first quarter of fiscal year 2006. The Company issued
warrants during the reporting periods, and as such, applied FAS 123R and EITF
96-18 in reporting these transactions on the Company's financial statements.

In December 2004, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards ("SFAS") No. 151, "Inventory Costs."
SFAS No. 151 requires abnormal amounts of inventory costs related to idle
facility, freight handling and wasted material expenses to be recognized as
current period charges. Additionally, SFAS No. 151 requires that allocation of
fixed production overheads to the costs of conversion be based on the normal
capacity of the production facilities. The standard is effective for fiscal
years beginning after June 15, 2005. The adoption of SFAS No. 151 did not have
an impact on the Company's financial position or results of operations.

In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections." SFAS No. 154 replaces Accounting Principles Board ("APB") Opinion
No. 20, "Accounting Changes" and SFAS No. 3, "Reporting Accounting Changes in
Interim Financial Statements." SFAS No. 154 requires retrospective application
to prior periods' financial statements of a voluntary change in accounting
principle unless it is impracticable. APB No. 20 previously required that most
voluntary changes in accounting principle be recognized by including the
cumulative effect of changing to the new accounting principle in net income in
the period of the change. SFAS No. 154 is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2005.
The adoption of SFAS No. 154 did not have an impact on the Company's financial
position or results of operations.

                                       15
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

In February 2006, the FASB issued SFAS No. 155, "Accounting for Certain Hybrid
Financial Instruments, an amendment of FASB Statements No. 133 and 140." SFAS
No. 155 resolves issues addressed in SFAS No. 133 Implementation Issue No. D1,
"Application of Statement 133 to Beneficial Interests in Securitized Financial
Assets," and permits fair value remeasurement for any hybrid financial
instrument that contains an embedded derivative that otherwise would require
bifurcation, clarifies which interest-only strips and principal-only strips are
not subject to the requirements of SFAS No. 133, establishes a requirement to
evaluate interests in securitized financial assets to identify interests that
are freestanding derivatives or that are hybrid financial instruments that
contain an embedded derivative requiring bifurcation, clarifies that
concentrations of credit risk in the form of subordination are not embedded
derivatives and amends SFAS No. 140 to eliminate the prohibition on a qualifying
special-purpose entity from holding a derivative financial instrument that
pertains to a beneficial interest other than another derivative financial
instrument. SFAS No. 155 is effective for all financial instruments acquired or
issued after the beginning of the first fiscal year that begins after September
15, 2006. The adoption of SFAS No. 155 is not anticipated to have a material
impact on the Company's financial position, results of operations or cash flows.


In March 2006, the FASB issued SFAS No. 156, "Accounting for Servicing of
Financial Assets", an amendment of FASB Statement No. 140. SFAS No. 156 requires
an entity to recognize a servicing asset or liability each time it undertakes an
obligation to service a financial asset by entering into a servicing contract
under a transfer of the servicer's financial assets that meets the requirements
for sale accounting, a transfer of the servicer's financial assets to a
qualified special-purpose entity in a guaranteed mortgage securitization in
which the transferor retains all of the resulting securities and classifies them
as either available-for-sale or trading securities in accordance with SFAS No.
115, "Accounting for Certain Investments in Debt and Equity Securities" and an
acquisition or assumption of an obligation to service a financial asset that
does not relate to financial assets of the servicer or its consolidated
affiliates. Additionally, SFAS No. 156 requires all separately recognized
servicing assets and servicing liabilities to be initially measured at fair
value, permits an entity to choose either the use of an amortization or fair
value method for subsequent measurements, permits at initial adoption a one-time
reclassification of available-for-sale securities to trading securities by
entities with recognized servicing rights and requires separate presentation of
servicing assets and liabilities subsequently measured at fair value and
additional disclosures for all separately recognized servicing assets and
liabilities. SFAS No. 156 is effective for transactions entered into after the
beginning of the first fiscal year that begins after September 15, 2006. The
adoption of SFAS No. 156 is not anticipated to have a material impact on the
Company's financial position, results of operations or cash flows.

                                       16
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

In June 2006, the FASB issued Interpretation No. 48, "Accounting for Uncertainty
in Income Taxes" (FIN 48), which clarifies the accounting for uncertainty in
income taxes recognized in an enterprise's financial statements in accordance
with SFAS No. 109, "Accounting for Income Taxes." FIN 48 establishes a
recognition threshold and measurement attribute for the financial statement
recognition and measurement of a tax position taken or expected to be taken in a
tax return. This interpretation also provides guidance on de-recognition,
classification, interest and penalties, accounting in interim periods,
disclosure, and transition. FIN 48 is effective for fiscal years beginning after
December 15, 2006. The adoption of FIN 48 is not anticipated to have a material
impact on the Company's financial position, results of operations or cash flows.

In September 2006, The Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards ("SFAS") No. 157, "Fair Value
Measurement" ("SFAS No. 157"). This standard provides guidance for using fair
value to measure assets and liabilities. SFAS No. 157 applies whenever other
standards require (or permit) assets or liabilities to be measured at fair value
but does not expand the use of fair value in any new circumstances. Prior to
SFAS No. 157, the methods for measuring fair value were diverse and
inconsistent, especially for items that are not actively traded. The standard
clarifies that for items that are not actively traded, such as certain kinds of
derivatives, fair value should reflect the price in a transaction with a market
participant, including an adjustment for risk, not just the company's
mark-to-model value. SFAS No. 157 also requires expanded disclosure of the
effect on earnings for items measured using unobservable data. SFAS No. 157 is
effective for financial statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal years. The Company is
currently evaluating the impact of this statement on its financial statements
and expects to adopt SFAS No.157 on December 31, 2007.

In September 2006, the FASB issued SFAS No. 158, "Employers' Accounting for
Defined Benefit Pension and Other Postretirement Plans -- An Amendment of FASB
Statements No. 87, 88, 106, and 132R." This standard requires an employer to:
(a) recognize in its statement of financial position an asset for a plan's
overfunded status or a liability for a plan's underfunded status; (b) measure a
plan's assets and its obligations that determine its funded status as of the end
of the employer's fiscal year (with limited exceptions); and (c) recognize
changes in the funded status of a defined benefit postretirement plan in the
year in which the changes occur. Those changes will be reported in comprehensive
income. The requirement to recognize the funded status of a benefit plan and the
disclosure requirements are effective as of the end of the fiscal year ending
after December 15, 2006. The requirement to measure plan assets and benefit
obligations as of the date of the employer's fiscal year-end statement of
financial position is effective for fiscal years ending after December 15, 2008.
The adoption of FAS 158 is not anticipated to have a material impact on the
Company's financial position or results of operations.

                                       17
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option for
Financial Assets and Liabilities, including an amendment of FASB Statement No.
115" ("SFAS No. 159"). SFAS No. 159 permits entities to choose, at specified
election dates, to measure many financial instruments and certain other items at
fair value that are not currently required to be measured at fair value.
Unrealized gains and losses shall be reported on items for which the fair value
option has been elected in earnings at each subsequent reporting date. SFAS No.
159 is effective for fiscal years beginning after November 15, 2007. Early
adoption is permitted as of the beginning of a fiscal year that begins on or
before November 15, 2007, provided the entity also elects to apply the
provisions of SFAS No. 157 "Fair Value Measurements" ("SFAS No. 157"). The
Company is currently assessing the impact that SFAS No. 159 will have on its
financial statements.

NOTE 3 - SECURITIES AVAILABLE FOR SALE

On February 13, 2007, the Company received 4,000,000 shares for Deep Field
Technologies Class A Common Stock as compensation pursuant to the Consulting
Agreement with Deep Field Technologies, valued at $1,120,000. The Company shall
provide "general corporate finance advisory and other similar consulting
services" for a period of six (6) months from the date of the agreement. At
March 31, 2007, the book value of these securities is $1,120,000 and the market
value is $280,000. The cumulative unrealized loss of $840,000 is included in the
Other Comprehensive (Loss). The President and CEO of the Company was also the
President and CEO of Deep Field Technologies prior to execution of the
Consulting Agreement. As such, this transaction is a related party transaction.


                                       18
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 4 - GOODWILL

On September 21, 2006, the Company concluded the acquisition of Genotec
Nutritionals, Inc. Pursuant to the Asset Purchase Agreement, the Company issued
10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato. The calculation
of Goodwill is as follows:

   Common stock issued                                       $   300,000
   Plus liabilities assumed:
      Accounts payable and accrued expense                       169,254
                                                             -----------
      Total purchase price                                       469,254

   Less assets acquired:
      Accounts receivable                                        179,002
      Inventory                                                   34,191
      Prepaid expenses                                             2,149
      Security deposit                                             3,183
                                                             -----------
   Total Goodwill                                            $   250,729
                                                             ===========

NOTE 5 - INCOME TAXES

Deferred tax assets and liabilities reflect the net tax effect of temporary
differences between the carrying amount of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. Significant
components of the Company's deferred tax assets and liabilities are summarized
as follows:

                                                             At March 31,
                                                                 2007
                                                             -----------

         Deferred tax asset                                  $ 1,581,000
         Less:  Valuation allowance                           (1,581,000)
                                                             -----------
         Net deferred tax assets                             $      --
                                                             ===========

As of March 31, 2007, the Company has net operating loss carry forwards of
approximately $4,650,000 that can be utilized to offset future taxable income
for Federal income tax purposes through 2026. Utilization of these net loss
carry forwards is subject to the limitations of Internal Revenue Code Section
382. Because of the current uncertainty of realizing the benefit of the tax
carry forward, a valuation allowance equal to the tax benefit for deferred taxes
has been established. The full realization of the tax benefit associated with
the carry forward depends predominantly upon the Company's ability to generate
taxable income during the carry forward period.

                                       19
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 6 - RELATED PARTY TRANSACTIONS

As of March 31, 2007, the Company has accrued $684,445 of deferred compensation
for the Non-executive Chairman and the President of the Company. These deferrals
will remain unpaid until the Board of Directors determines that the Company has
sufficient liquidity to make such payments. The Non-executive Chairman and the
President of the Company have further agreed, however, to accept payment or
partial payment, from time to time, in the form of the Company's Class A Common
Stock and/or the Company's Class B Company Stock, at such time as the Board of
Directors determines to issue such shares in satisfaction of these accrued
liabilities.

NOTE 7 - CONVERTIBLE DEBENTURES PAYABLE

On April 1, 2005, we entered into a Securities Purchase Agreement with Cornell
for the sales of $2,500,000 of secured convertible debentures. The agreement was
amended and restated on July 20, 2006 and January 4, 2007 to reflect the change
in the funding formulas. Pursuant to the terms of the agreement with Cornell, on
April 1, 2005 we issued a secured convertible debenture in the principal amount
of $1,250,000. On July 20, 2006, the secured convertible debenture was amended
and restated and reissued in an aggregate principal amount of $1,330,308, which
included accrued and unpaid interest on the original convertible debenture of
$80,308. Interest on the outstanding principal balance of the Secured
Convertible Debentures accrues at the annual rate of 10%. Payment of principal
and accrued interest shall be paid on or before July 1, 2008 on the July 20,
2006 debenture. During the nine months ended March 31, 2007, we issued 3,086,420
shares of Class A common stock as repayment of principal of $50,000. As of March
31, 2007 the remaining principal balance of the convertible debenture was
$1,280,308 plus $91,506 of accrued interest.

On January 4, 2007, we issued a secured convertible debenture in the principal
amount of $625,000. Interest on the outstanding principal balance of this
Secured Convertible Debentures accrues at the annual rate of 10%. Payment of
principal and accrued interest shall be paid on or before January 1, 2009. As of
March 31, 2007 the remaining principal balance of the convertible debenture was
$625,000 plus $14,726 of accrued interest.

The Company has the option to redeem a portion or all of the outstanding
debentures at 120% of the amount redeemed plus accrued interest. The holder
shall be entitled to convert in whole or in part at any time and from time to
time, any amount of principal and accrued interest at a price equal to 90% of
the lowest closing bid price of the Common Stock during the 30 trading days
immediately preceding the conversion date, as quoted by Bloomberg, LP
("Conversion Price").

                                       20
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 7 - CONVERTIBLE DEBENTURES PAYABLE (CONTINUED)

In the event of a default, the full principal amount of this Debenture, together
with interest and other amounts owing, shall be due and payable in cash,
provided however, the holder of the debenture may request payment of such
amounts in Common Stock of the Obligor at the Conversion Price then in-effect. A
holder of the debenture may not convert this Debenture or receive shares of
Common Stock as payment of interest hereunder to the extent such conversion or
receipt of such interest payment would result in the holder of the debenture
beneficially owning in excess of 4.9% of the then issued and outstanding shares
of Common Stock, including shares issuable upon conversion of, and payment of
interest on, this Debenture.

Upon execution of the July 20, 2006 agreements, the Company issued to Cornell
1,849,689 shares of Class A common stock, in accordance with the Termination
Agreement of July 20, 2006, and another certificate for 3,150,311 shares of
Class A common stock, for the aggregate total of 5,000,000 shares of Common
Stock (collectively, the "Commitment Shares").

The aggregate principal value of the Amended and Restated Secured Convertible
Debenture is $1,905,308. This amount is shown net of the unamortized portion of
the discount on conversion of $1,272,972. This discount is being amortized over
the life of the debenture and is being recorded as a charge to amortization of
discount on debt conversion on the statement of operations.

NOTE 8 - DERIVATIVE LIABILITY

In accordance with SFAS 133, "Accounting for Derivative Instruments and Hedging
Activities" and EITF 00-19, "Accounting for Derivative Financial Instruments
Indexed to, and Potentially Settled in, a Company's Own Stock", the conversion
feature associated with the Cornell Secured Convertible Debentures represents
embedded derivatives. As such, the Company had recognized embedded derivatives
in the aggregate amount of $2,642,352 as a liability in the accompanying
condensed consolidated balance sheet, and it is now measured at its estimated
fair value of $1,769,516.

The estimated fair value of the embedded derivative has been calculated based on
a Black-Scholes pricing model using the following assumptions:

      Fair market value of stock                                  $0.040
      Lowest closing bid price last 30 trading days               $0.040
      Exercise price                                              $0.036
      Dividend yield                                               0.00%
      Risk free interest rate                                      5.60%
      Expected volatility                                         227.60%
      Expected life                                          1.25 - 1.75 Years

                                       21
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006


NOTE 8 - DERIVATIVE LIABILITY (CONTINUED)

The derivative value of the January 4, 2007 debenture exceeded the face amount
of the debenture and as such, the excess value of $855,597 was charged to the
Loss on revaluation of derivatives on the condensed consolidated statements of
operations.

Changes in the fair value of the embedded derivatives are calculated at each
reporting period and recorded in gain on revaluation of derivatives in the
condensed consolidated statements of income (loss). During the nine months ended
March 31, 2007, there was a change in the fair value of the embedded
derivatives, which resulted in a gain of $798,215.

During the nine months ended March 31, 2007, the Company paid down a portion of
one of the Cornell Debentures by the issuance of common stock for an aggregate
of $50,000. The effect on the reduction in the fair value of the embedded
derivatives of $74,621 was recorded as Additional paid-in capital on the
condensed consolidated balance sheet.

In accordance with SFAS 133, SFAS 150 and EITF 00-19, the initial fair market
value of the derivatives is recorded as a debt discount. The initial value of
the debt discount of $1,786,755 is being amortized over the life of the
convertible debentures. Amortization expense on the derivative for the nine
months ended March 31, 2007 was $513,783.

NOTE 9 - TEMPORARY EQUITY

As of March 31, 2007, the Company does not have sufficient quantity of
authorized Class A common stock to meet it potential obligations for conversions
of the Class B common stock, the Cornell Secured Convertible Debentures and the
Cornell Warrants. The Class B common stock is convertible into approximately 1.2
billion shares of Class A common stock. The Cornell Secured Convertible
Debentures are convertible into approximately 53 million shares of Class A
common stock. The Cornell Warrants are convertible into approximately 21 million
shares of Class A common stock. The accounts due to related parties are
convertible into approximately 84 million shares of Class A common stock. The
aggregate amount of shares outstanding and those due upon these conversions is
in excess of 1.5 billion, which exceeds the 450 million authorized in the
Certificate of Incorporation. As such, this account has been reclassified to
temporary equity until the situation can be resolved. Management intends to
remedy this situation by increasing the number of authorized shares with the
consent of the shareholders, or, alternatively, seeking a written forbearance
from the holders of the Class B Common Stock whereby those holders will consent
to not converting their Class B Common Stock to Class A Common Stock unless and
until there is sufficient Class A Common Stock authorized by the Corporation to
honor such conversion.

                                       22
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 10 - STOCKHOLDERS' DEFICIT

In accordance with its Certificate of Incorporation as filed on July 7, 2005,
the Company is authorized to issue 1,000,000 shares of Preferred stock, $1.00
par value, 450,000,000 shares of Class A common stock, no par value; and
50,000,000 shares of Class B Common Stock, no par value.

PREFERRED STOCK

Preferred Stock consists of 1,000,000 shares of authorized preferred stock with
$1.00 par value. As of March 31, 2007, no shares were issued or outstanding.

CLASS A COMMON STOCK

Class A Common Stock consists of the following as of March 31, 2007: 450,000,000
shares of authorized common stock with no par value, 145,727,523 shares were
issued and outstanding. Each holder of Class A common stock is entitled to
receive ratably dividends, if any, as may be declared by the Board of Directors
out of funds legally available for the payment of dividends. The Company has
never paid any dividends on its common stock and does not contemplate doing so
in the foreseeable future. The Company anticipates that any earnings generated
from operations will be used to finance the growth objectives.

For the nine months ended March 31, 2007, the Company had the following
transactions in its Class A common stock:

     On July 20, 2006, the Company issued 1,849,689 shares of Class A common
     stock with a total value of $120,230, which represents full satisfaction of
     the Commitment Shares under the Standby Equity Distribution Agreement,
     pursuant to the Termination Agreement of July 20, 2006.

     On July 20, 2006, the Company issued 3,150,311 shares of Class A common
     stock with a total value of $204,770, for Commitment Shares pursuant to the
     Amended and Restated Securities Purchase Agreement of July 20, 2006.

     On August 10, 2006, the Company issued 1,411,765 shares of its Class A
     common stock with a total value of $77,005, as compensation for the
     strategic alliance with UTEK Corporation to identify synergistic technology
     acquisition opportunities in the future. These shares were subsequently
     cancelled on March 1, 2007.

     On September 5, 2006, the Company issued 600,000 shares of its Class A
     common stock with a total value of $30,000, as compensation to Stephen Wien
     for services provided.

                                       23
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 10 - STOCKHOLDERS' DEFICIT (CONTINUED)

On September 21, 2006, the Company concluded the acquisition of Genotec
Nutritionals, Inc. Pursuant to the Asset Purchase Agreement, the Company issued
10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato.

On October 6, 2006, the Company issued 300,000 shares of its Class A common
stock with a total value of $10,500, as compensation for the consulting services
with Allison Investment Corp. on matters related to mergers and acquisitions.

On January 16, 2007, the Company issued 100,000 restricted shares of its' Class
A Common Stock with a total value of $4,000, to Dr. Yevsey Belinky for the
continuing development of a new cardiac supplement product line.

On January 16, 2007, the Company issued 500,000 restricted shares of its' Class
A Common Stock with a total value of $25,000, to William Maier pursuant to his
consulting agreement for product marketing services.

On January 29, 2007, the Company issued 3,086,420 restricted shares of its'
Class A Common Stock to Cornell Capital Partners upon conversion of $50,000 of
the Cornell Convertible Debentures.

On March 1, 2007, the Company issued 2,000,000 restricted shares of its' Class A
Common Stock with a total value of $112,000, to Dr. Jeffrey Shapiro, and his
assignees, as a partial fee for joining the Company's Board of Scientific
Advisors and for providing the Company consulting services relating to the
development of a new cardiac supplement product line.

On March 1, 2007, the Company terminated it agreement with UTEK Corporation and
canceled the 1,411,725 shares of Class A Common Stock previously issued. The
Company reissued 825,852 shares of its' Class A Common Stock with a total value
of $45,046, in settlement of all fees earned through the termination date.

                                       24
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 10 - STOCKHOLDERS' DEFICIT (CONTINUED)

CLASS B COMMON STOCK

As of March 31, 2007, Class B Common Stock consisted of 50,000,000 shares of
authorized common stock with no par value, 10,000,000 shares were issued and
outstanding. Class B stock has voting rights of 100 to 1 with respect to Class A
Common Stock. Class B common stockholders are entitled to receive dividends in
the same proportion as the Class B Common Stock conversion and voting rights
have to Class A Common Stock. A holder of Class B Common Stock has the right to
convert each share of Class B Common Stock into the number of shares of Class A
Common Stock determined by dividing the number of Class B Common Stock being
converted by a 50% discount of the lowest price that the Company had ever issued
its Class A Common Stock. Upon the liquidation, dissolution, or winding-up of
the Company, holders of Class B Common Stock will be entitled to receive
distributions.

NOTE 11 - WARRANTS

On April 1, 2005, the Company sold to Cornell Capital a warrant to purchase
750,000 shares of its common stock for a purchase price of $10. This warrant had
an exercise price of $.07 per shares, was vested immediately and expires two
years from the date of issue. On July 20, 2006, the Company issued an Amended
and Restated warrant which changed the exercise price to $.05 per share and
extended the redemption period to five years from the date of issuance. The fair
value of the amended warrant of $44,625 was estimated using the Black-Scholes
option-pricing model with the following weighted-average assumptions: dividend
yield of 0%; expected volatility of 142.21%; risk-free interest rates of 4.60%;
and expected life of 5 years. The gain on the disposition of the initial warrant
was credited to other income for $40,192. The expense for the amended warrant of
$44,625 was charged to financing costs.

NOTE 12 - COMMITMENTS AND CONTINGENCIES

The Company entered into two employment agreements with Jerome Mahoney, its
Non-executive Chairman of the Board and Mark Meller, its President and Board
Member, as of December 15, 2004. Each of the employment agreements is for a term
through March 31, 2011 and provides for annual compensation of $200,000 with an
annual increase of 10%. In addition, each executive shall be entitled to Company
sponsored fringe benefits and annual bonuses in accordance with the Company
policies and plans in effect for Executive officers of the Company. The
executives shall also be granted stock options under the Company's stock option
plan as adopted by the Board of Directors and the shareholders of the Company.
The executives will each receive a $750,000 bonus for the successful completion
of the registration of the Company's stock on Form S-1, SB-2 and any other such
form of registration statement declared effective by the Securities and Exchange
Commission. This bonus shall be paid in a lump sum on the date the registration
statement is declared effective, or alternately, at the discretion of the
Company and with the agreement of the Executive, in shares of the Company's
Class B Common Stock.

                                       25
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 12 - COMMITMENTS AND CONTINGENCIES (CONTINUED)

On October 1, 2006, the Company entered into a sub-lease with SWK Technologies,
Inc. for an office located at 5 Regent Street, Suite 520, Livingston, NJ 07052.
The rent is on a month-to-month basis for $350 per month SWK Technologies, Inc.
is a wholly-owned subsidiary of Trey Resources, Inc. We use these facilities to
house our corporate headquarters and operations and believe our facilities are
suitable for such purpose.

On February 1, 2005, our wholly owned subsidiary, Genotec Nutritionals amended
its operating lease for office and warehouse space at 450 Commack Road, Deer
Park, NY. The term of the lease is four years commencing March 1, 2005. Monthly
base rental payments under the new lease range from $3,067 to $3,354 per month.
We are required to pay property taxes, utilities, insurance and other costs
relating to the leased facilities to include allocated common area maintenance
charges, snow removal charges and landlord insurance charges as deemed
necessary.

NOTE 13 - GOING CONCERN

The accompanying condensed consolidated financial statements have been prepared
in conformity with accounting principles generally accepted in the United States
of America, which contemplates continuation of the Company as a going concern.

The Company has suffered recurring losses and experiences a deficiency of cash
flow from operations. These matters raise substantial doubt about the Company's
ability to continue as a going concern. The recoverability of a major portion of
the recorded asset amounts shown in the accompanying condensed consolidated
balance sheet is dependent upon continued operations of the Company, which in
turn, is dependent upon the Company's ability to raise capital and/or generate
positive cash flows from operations.

The Company is actively evaluating business combinations, through mergers or
acquisitions that will provide sales growth potential and positive cash flows.
As an example, on September 21, 2006, the Company completed the acquisition of
Genotec Nutritionals, Inc, a New York based manufacturer and distributor of
nutritional supplements and vitamins. Management believes that this is an
excellent opportunity to enter into the nutraceuticals market by acquiring an
existing company with an established customer base.

These condensed consolidated financial statements do not include any adjustments
relating to the recoverability and classification of recorded assets, or the
amounts and classification of liabilities that might be necessary in the event
the Company cannot continue in existence.

                                       26
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                             MARCH 31, 2007 AND 2006

NOTE 14 - RESTATEMENT

The Company has restated and amended its previously issued financial statement
for the nine months ended March 31, 2006. The Company had amended the financial
statements to correct the accounting for the intrinsic value of the convertible
debentures issued April 1, 2005. In addition, changes in the amortization of the
discount in the amount of $282,605 was credited to operations. The net effect
decreased the previously reported loss of $2,454,899 to a loss of $2,172,294. In
addition, the changes decreased the accumulated deficit to $2,777,632.

                                       27
<PAGE>

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

         You should read the following discussion in conjunction with our
financial statements and related notes included elsewhere in this filing as well
as our audited statements and related notes for the fiscal year ended June 30,
2006 filed with Form 10-KSB. The following discussion contains forward-looking
statements. Please see "Forward Looking Statements - Cautionary Factors" for a
discussion of uncertainties, risks and assumptions associated with these
statements

PLAN OF OPERATION

         On September 21, 2006, the Company completed the acquisition Genotec
Nutritionals, Inc., a distributor and marketer of nutritional supplements and
vitamins. The Company intends to develop businesses in the nutraceutical market
via internal growth and product development, and by acquisition of other
companies that operate in that market. The Company does retain the right and
flexibility, however, to complete acquisition or merger transactions in other
markets or industries.

         The Company has a limited operating history on which to base an
evaluation of its business and prospects. Its prospects must be considered in
light of the risks, expenses and difficulties frequently encountered by
companies in their early stage of development, particularly companies in new and
rapidly evolving markets. The Company will encounter various risks in
implementing and executing its business strategy. The Company can provide no
assurance that it will be successful in addressing such risks, and the failure
to do so could have a material adverse effect on its business.

         The officers and directors of the Company are currently involved in
other activities, and devote only a portion of their time to the specific
business affairs of the Company.

         We may have significant changes in the numbers of employees in the next
twelve months, contingent upon the continued growth and success of the Company's
Genotec Nutritionals operating subsidiary.

MERGERS AND ACQUISITIONS

         On September 21, 2006, the Company completed the previously announced
acquisition of Genotec Nutritionals, Inc, a New York based manufacturer and
distributor of nutritional supplements and vitamins. The Company issued
10,000,000 shares of its Class A Common Stock as part of the purchase price. The
Company also purchased $75,000 of Genotec's Series A Convertible Preferred
Stock, which represented working capital for the new subsidiary.

                                       28
<PAGE>

RESULTS OF OPERATIONS

NINE MONTHS ENDED MARCH 31, 2007 COMPARED TO NINE MONTHS ENDED MARCH 31, 2006

         Prior to the acquisition of Genotec Nutritionals, Inc ("Genotec") on
September 21, 2006, the Company had no sales and limited operations.
Consequently, comparison of the current period results to prior period results
may not be meaningful.

         Total sales for the nine months ended March 31, 2007 and 2006 were
$674,230 and $0, respectively. The increase in sales in 2007 was derived from
the sales of nutritional supplements and vitamins by our wholly owned
subsidiary, Genotec.

         Cost of sales for the nine months ended March 31, 2007 and 2006 were
$250,864 and $0, respectively. The costs in 2007 represent the costs of bulk
supplies of raw ingredients, capsules and sealed powders, bottles, caps,
shipping containers, packaging and shipping of nutritional supplements and
vitamins by Genotec.

         Total operating expenses for the nine months ended March 31, 2007 and
2006, were $1,234,073 and $557,636, respectively. The increase of $676,437 was
primarily due to the effect of the Genotec acquisition, increases in
professional and consulting fees related to the Genotec acquisition, and
increases in accounting fees for audit and review work associated with being a
public reporting company. Operating expenses increased by $496,127 for Genotec
administration, selling and marketing expenses. The most significant portion of
the Genotec expenses were related new consulting agreements for product
development and product marketing of $186,213. Genotec's other most significant
operating expenses were related to payroll related expenses of $196,632, rent
and utilities of $32,125, insurance of $18,330 and selling expenses of $27,960.

         Total other (income) expense for the nine months ended March 31, 2007
was an expense of $831,094. This total was comprised of amortization of the
discount on debt conversion of $513,783, loss on revaluation of derivatives of
$57,382, write-off of financing costs of $369,625, interest expense of $108,589
and liquidated damages of $119,531. These amounts are offset by consulting
income of $280,000 on the Deep Field Consulting Agreement, interest income of
$17,624 and gain on disposition of derivative liability of $40,192. The other
expense for the nine months ended March 31, 2006 was an expense of $1,614,658.
This total was comprised of amortization of the discount on debt conversion of
$500,000, interest expense of $130,902 and write-off of financing costs of
$1,005,004 on the warrants issued to Cornell Capital. These amounts are offset
by interest income of $21,248. Interest expense is related to accrued interest
on the Cornell Debentures and interest income is related to interest on the cash
accounts.

         Net loss from operations for the nine months ending March 31, 2007 and
2006, was $1,641,801 and $2,172,294, respectively, as the result of the factors
discussed above. Comparison of the current period to the prior period may not be
meaningful for the reasons discussed above.

                                       29
<PAGE>

THREE MONTHS ENDED MARCH 31, 2007 COMPARED TO THREE MONTHS ENDED MARCH 31, 2006

         Prior to the acquisition of Genotec Nutritionals, Inc ("Genotec") on
September 21, 2006, the Company had no sales and limited operations.
Consequently, comparison of the current period results to prior period results
may not be meaningful.

         Total sales for the three months ended March 31, 2007 and 2005 were
$247,954 and $0, respectively. The increase in sales in 2007 was derived from
the sales of nutritional supplements and vitamins by Genotec.

         Cost of sales for the three months ended March 31, 2007 and 2006 were
$96,610 and $0, respectively. The costs in 2007 represent the costs of bulk
supplies of raw materials, capsules and sealed powders, bottles, caps, shipping
containers, packaging and shipping of nutritional supplements and vitamins by
Genotec.

         Total operating expenses for the three months ended March 31, 2007 and
2006, were $643,941 and $185,644, respectively. The increase of $458,297 was
primarily due to the effect of the Genotec acquisition, increases in
professional and consulting fees related to identifying and researching
potential acquisitions, and increases in accounting fees for audit and review
work associated with being a public reporting company. Operating expenses
increased by $342,598 for Genotec administration and selling and marketing
expenses. The most significant portion of the Genotec expenses were related new
consulting agreements for product development and product marketing of $185,644.
Genotec's other most significant operating expenses were related to payroll
related expenses of $93,475, rent and utilities of $17,831, insurance of $10,617
and selling expenses of $20,460.

         Total other (income) expense for the three months ended March 31, 2007
was an income of $746,820. This total was comprised of gain on revaluation of
derivatives of $766,235, consulting income of $280,000 on the Deep Field
Consulting Agreement and interest income of $8,496. These amounts are offset by
amortization of the discount on debt conversion of $223,344, interest expense of
$46,460 and liquidated damages of $38,107. The other expense for the three
months ended March 31, 2006 was an expense of $823,903. This total was comprised
of interest expense of $15,624 and write off of financing costs of $964,812.
These amounts are offset by interest income of $6,533 and a reversal of
liquidated damages of $150,000. Interest expense is related to accrued interest
on the Cornell Debentures and interest income is related to interest on the cash
accounts.

         Net income from operations for the three months ending March 31, 2007
was $254,223 and the net loss from operations for the three months ending March
31, 2006 was $1,009,547, as the result of the factors discussed above.
Comparison of the current period to the prior period may not be meaningful for
the reason discussed above.

                                       30
<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

         On April 1, 2005, we entered into a Securities Purchase Agreement with
Cornell for the sale of $2,500,000 of secured convertible debentures. The
agreement was amended and restated on July 20, 2006 and January 4, 2007 to
reflect the change in the funding formulas. Pursuant to the terms of the
agreement with Cornell, on April 1, 2005 we issued a secured convertible
debenture in the principal amount of $1,250,000. On July 20, 2006, the secured
convertible debenture was amended and restated and reissued in an aggregate
principal amount of $1,330,308, which included accrued and unpaid interest on
the original convertible debenture of $80,308. On January 4, 2007, we issued a
second secured convertible debenture to Cornell in the principal amount of
$625,000. In addition, we will issue a third secured convertible debenture in
the principal amount of $625,000, two (2) business days prior to the date the
registration statement, registering the resale of the shares of Class A Common
Stock issuable upon conversion of convertible debentures and exercise of the
warrants, is declared effective by the SEC. These debentures will be convertible
into Class A common stock at the discretion of the holders. These transactions
will require the Company to register for resale a number of shares to facilitate
these financial transactions.

         The Company is seeking additional operating income opportunities
through potential acquisitions or investments. Such acquisitions or investments
may consume cash reserves or require additional cash or equity. Our working
capital and additional funding requirements will depend upon numerous factors,
including: (i) strategic acquisitions or investments; (ii) an increase to
current company personnel; (iii) the level of resources that we devote to sales
and marketing capabilities; (iv) technological advances; and (v) the activities
of competitors.

         To date, the Company has incurred substantial losses, and will require
financing for working capital to meet its operating obligations. While we have
raised sufficient working capital to fund our operations for what we believe
should be sufficient for the next 12 months, we will subsequently need to raise
additional capital to fund our future operations. We anticipate that we will
require financing on an ongoing basis for the foreseeable future to fund our
working capital needs.

         During the nine months ended March 31, 2007 the Company had a net
increase in cash of $223,281 and during the nine months ended March 31, 2006,
the Company had a net decrease in cash of $443,552, respectively. The Company's
principal use of funds during these periods was as follows:

         CASH FLOWS FROM OPERATING ACTIVITIES. The Company used $399,523 in cash
for operations in the nine months ended March 31, 2007, a decrease of $43,473
compared to $442,996 in cash used for operations in the nine months ending March
31, 2006. The decrease in cash used in operations was primarily the result of
lower net cash loss (net loss after adding back non-cash items but before
considering changes in certain assets and liabilities) of $830,897 and a
favorable change in prepaid expenses of $43,981, accounts payable and accrued
liabilities of $490,945 and related party accounts of $216,390, offset by
increases in inventory of $208,915 and accounts receivable of $111,027.

         CASH FLOWS FROM INVESTING ACTIVITIES. The Company used cash of $2,196
for investing activities in the nine months ended March 31, 2007 for the
purchase of new office computer

                                       31
<PAGE>

equipment for Genotec following the acquisition. The Company used cash of $556
for investing activities in the nine months ended March 31, 2006 to upgrade the
computers for the home office.

         CASH FLOWS FROM FINANCING ACTIVITIES. The Company provided $625,000
cash from financing in the nine months ended March 31, 2007. This represented
the net proceeds from the sale of a $625,000 Secured Convertible Debenture to
Cornell Capital Partners.

FORWARD LOOKING STATEMENTS - CAUTIONARY FACTORS

Certain information included in this Form 10-QSB and other materials filed or to
be filed by us with the Securities and Exchange Commission (as well as
information included in oral or written statements made by us or on our behalf),
may contain forward-looking statements about our current and expected
performance trends, growth plans, business goals and other matters. These
statements may be contained in our filings with the Securities and Exchange
Commission, in our press releases, in other written communications, and in oral
statements made by or with the approval of one of our authorized officers.
Information set forth in this discussion and analysis contains various
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private
Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe
harbor" provisions for forward-looking statements. The reader is cautioned that
such forward-looking statements are based on information available at the time
and/or management's good faith belief with respect to future events, and are
subject to risks and uncertainties that could cause actual performance or
results to differ materially from those expressed in the statements.
Forward-looking statements speak only as of the date the statement was made. We
assume no obligation to update forward-looking information to reflect actual
results, changes in assumptions or changes in other factors affecting
forward-looking information. Forward-looking statements are typically identified
by the use of terms such as "anticipate," "believe," "could," "estimate,"
"expect," "intend," "may," "might," "plan," "predict," "project," "should,"
"will," and similar words, although some forward-looking statements are
expressed differently. Although we believe that the expectations reflected in
such forward-looking statements are reasonable, we can give no assurance that
such expectations will prove to be correct. For a discussion of material risks
and uncertainties that the Company faces, see the discussion in the Form 10-KSB
for the fiscal year ended June 30, 2006 entitled "Risk Factors".

                                       32
<PAGE>

ITEM 3. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES.

The Company maintains a set of disclosure controls and procedures designed to
ensure that information required to be disclosed by us in our reports filed
under the Securities Exchange Act, is recorded, processed, summarized, and
reported within the time periods specified by the SEC's rules and forms.
Disclosure controls are also designed with the objective of ensuring that this
information is accumulated and communicated to our management, including our
chief executive officer and chief financial officer, as appropriate, to allow
timely decisions regarding required disclosure.

Our Board of Directors were advised by Bagell, Josephs, Levine and Company, LLC,
our independent registered public accounting firm, that during their performance
of review procedures for the period ended March 31, 2007, they have identified a
material weakness as defined in Public Company Accounting Oversight Board
Standard No. 2 in our internal control over financial reporting. Our auditors
have identified the following material weakness in our internal controls:

     A material weakness in the Company's internal controls existed as of March
     31, 2007. The material weakness was identified as the Company's limited
     segregation of duties amongst the Company's employees with respect to the
     Company's preparation and review of the Company's financial statements.
     This material weakness is the result of the Company's limited number of
     employees. This material weakness may affect management's ability to
     effectively review and analyze elements of the financial statement closing
     process and prepare consolidated financial statements in accordance with
     U.S. GAAP.

Subsequent to the notification from our independent registered public accounting
firm, our chief executive officer evaluated our internal controls and concurred
that, since the date of formation, our disclosure controls and procedures have
not been effective to ensure that information required to be included in our
periodic SEC filings is recorded, processed, summarized, and reported within the
time periods specified in the SEC rules and forms. However, at this time, our
resources and size prevent us from being able to employ sufficient resources to
enable us to have adequate segregation of duties within our internal control
system. The Company intends to remedy the material weakness by hiring additional
employees and reallocating duties, including responsibilities for financial
reporting, among the Company's employees as soon as the Company has the
financial resources to do so. Management is required to apply its judgment in
evaluating the cost-benefit relationship of possible changes in our disclosure
controls and procedures.

                                       33
<PAGE>

CHANGES IN INTERNAL CONTROLS

Management of the Company has evaluated, with the participation of the Chief
Executive Officer of the Company, any change in the Company's internal control
over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) that occurred during the fiscal quarter covered by this Quarterly
Report on Form 10-QSB. There was no change in the Company's internal control
over financial reporting identified in that evaluation that occurred during the
fiscal quarter covered by this Quarterly Report on Form 10-QSB that has
materially affected, or is reasonably likely to materially affect, the Company's
internal control over financial reporting, other than what has been reported
above.

RISK FACTOR RELATED TO CONTROLS AND PROCEDURES

The Company has limited segregation of duties amongst its employees with respect
to the Company's preparation and review of the Company's financial statements
due to the Company's limited number of employees, which is a material weakness
in internal controls, and if the Company fails to maintain an effective system
of internal controls, it may not be able to accurately report its financial
results or prevent fraud. As a result, current and potential stockholders could
lose confidence in the Company's financial reporting which could harm the
trading price of the Company's stock.

Effective internal controls are necessary for the Company to provide reliable
financial reports and prevent fraud. Inferior internal controls could cause
investors to lose confidence in the Company's reported financial information,
which could have a negative effect on the trading price of the Company's stock.
Management has found it necessary to limit the Company's administrative staffing
in order to conserve cash, until the Company's level of business activity
increases. As a result, there is very limited segregation of duties amongst the
administrative employees, and the Company and its independent public accounting
firm have identified this as a material weakness in the Company's internal
controls. The Company intends to remedy this material weakness by hiring
additional employees and reallocating duties, including responsibilities for
financial reporting, among the Company's employees as soon as there are
sufficient resources available. However, until such time, this material weakness
will continue to exist. Despite the limited number of administrative employees
and limited segregation of duties, management believes that the Company's
administrative employees are capable of following its disclosure controls and
procedures effectively.

                                       34
<PAGE>

                           PART II - OTHER INFORMATION


ITEM 6. EXHIBITS


    31.1    Certification of Chief Executive and Chief Financial Officer
            pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section
            302 of the Sarbanes-Oxley Act of 2002.

    32.1    Certification of Chief Executive and Chief Financial Officer
            pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section
            906 of the Sarbanes-Oxley Act of 2002.






























                                       35
<PAGE>

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


MM2 Group, Inc.


By: /s/ Mark Meller                                        Date: May 21, 2007
    -----------------
Mark Meller, President,
Chief Executive Officer and
Principal Accounting Officer

























                                       36
<PAGE>

                                INDEX OF EXHIBITS


   31.1     Certification of Chief Executive and Chief Financial Officer
            pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section
            302 of the Sarbanes-Oxley Act of 2002.

   32.1     Certification of Chief Executive and Chief Financial Officer
            pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section
            906 of the Sarbanes-Oxley Act of 2002.































                                       37